Company:  GENMAB A/S (GMAB)
Form Type:  FWP
Filing Date:  7/16/2019 
CIK:  0001434265 
Address:  TOLDBODGADE 33 
City, State, Zip:  1253 COPENHAGEN K,  00000 
Last Trade
Last Trade: 
-0.04 (-0.18%)  
Trade Time: 
Dec 13  
Market Cap: 
Trade GMAB now with 

© 2019  
Description of Business
We are an international biotechnology company specializing in antibody therapeutics for the treatment of cancer and other diseases. Our core purpose is to improve the lives of patients by creating and developing innovative antibody products. Our vision is to transform cancer treatment by launching our own proprietary product by 2025 and advancing our pipeline of differentiated and well-tolerated antibodies. We are building and expanding our late-stage development and commercial capabilities to allow us to bring our proprietary products to market in the future. Today, we have a well-diversified portfolio of products, product candidates and technologies.
Register and access this filing in: